Eversense® CGM System, World's Longest Lasting CGM Sensor, Announces Approval and Launch of Remote Monitoring Feature for EMEA Markets

GERMANTOWN, Md.--(BUSINESS WIRE)-- Senseonics Holdings, Inc. (NYSE American: SENS) today announced that people with diabetes using the Eversense® brand Continuous Glucose Monitoring Systems, in EMEA markets now have the option to invite others to remotely view their real-time glucose readings and alerts from anywhere. The updated Eversense® app with remote monitoring allows up to 5 family members or friends to use Eversense® NOW, a remote monitoring application that automatically updates and displays glucose data sent from the Eversense system every 5 minutes to a mobile device. The Eversense® NOW user can remotely monitor the Eversense® user's CGM data in real time and be alerted of high or low glucose events, including predicted low/high glucose and glucose rate of change status.

"We are thrilled to bring this new product to people with diabetes, their families, and friends. The extra peace of mind and sense of community that comes when someone else can see your real-time glucose data is an important part of a comprehensive solution we want to offer to our customers,” said Tim Goodnow, CEO and President of Senseonics.

The updated Eversense® app and the Eversense® NOW app will both be available at no charge on the Apple App Store later this month. Development of the remote monitoring feature for Android users is in progress. The remote monitoring feature works with both the original Eversense® CGM System and the new extended life Eversense® XL CGM System.

About Senseonics

Senseonics Holdings, Inc. is a medical technology company focused on the design, development and commercialization of transformational glucose monitoring products designed to help people with diabetes confidently live their lives with ease. Senseonics' first generation product, the Eversense CGM System, includes a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every 5 minutes to a mobile app on the user's smartphone.

Forward Looking Statements

Certain statements contained in this press release, other than statements of fact that are independently verifiable at the date hereof, may constitute “forward-looking statements.” Although Senseonics believes that its plans, intentions, expectations, strategies and prospects as reflected in or suggested by those forward-looking statements are reasonable, Senseonics can give no assurance that the plans, intentions, expectations or strategies will be attained or achieved. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a variety of risks and factors that are beyond Senseonics’ control.

For further information regarding these risks, uncertainties and other factors you should read the “Risk Factors” section of our Annual Report on Form 10-K for the year ended December 31, 2016, our Quarterly Report on Form 10-Q for the quarter ended September 30, 2017 and our other filings we make with the Securities and Exchange Commission from time to time.

In addition, the forward-looking statements included in this press release represent Senseonics’ views as of the date hereof. Senseonics anticipates that subsequent events and developments will cause Senseonics’ views to change. However, while Senseonics may elect to update these forward-looking statements at some point in the future, Senseonics specifically disclaims any obligation to do so except as required by law. These forward-looking statements should not be relied upon as representing Senseonics’ views as of any date subsequent to the date hereof.

View source version on businesswire.com: http://www.businesswire.com/news/home/20180220006593/en/

Investors
Senseonics Holdings, Inc.
R. Don Elsey, 301-556-1602
Chief Financial Officer
[email protected]

Source: Senseonics Holdings, Inc.